{"entity":{"type":"insider","cik":"0001676170","url":"/insider/0001676170","json_url":"/insider/0001676170.json","name":"Coloma Jason V","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":6,"first":"2026-05-18","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Coloma Jason V","source":"filing","n_filings":6,"first_seen":"2026-05-18","last_seen":"2026-08-05"}],"transactions":[{"id":5987715,"accession":"0001676170-26-000016","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001676170-26-000016","line_url":"/filing/0001676170-26-000016","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34501.0,"shares_display":"34,501","price_per_share":26.732993788585837,"price_display":"26.73","price_state":"stated","total_value":922315.0187,"total_display":"922,315.02","total_whole":"922,315","shares_owned_after":256867.0,"shares_owned_after_display":"256,867","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider","n_lines":4},{"id":6114094,"accession":"0001676170-26-000014","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001676170-26-000014","line_url":"/filing/0001676170-26-000014","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34501.0,"shares_display":"34,501","price_per_share":29.977475522448625,"price_display":"29.98","price_state":"stated","total_value":1034252.883,"total_display":"1,034,252.88","total_whole":"1,034,253","shares_owned_after":288768.0,"shares_owned_after_display":"288,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":3},{"id":6078135,"accession":"0001676170-26-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001676170-26-000012","line_url":"/filing/0001676170-26-000012#line-3","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23865.0,"shares_display":"23,865","price_per_share":26.0496,"price_display":"26.05","price_state":"stated","total_value":621673.704,"total_display":"621,673.70","total_whole":"621,674","shares_owned_after":319079.0,"shares_owned_after_display":"319,079","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-24","scope":"insider"},{"id":6078133,"accession":"0001676170-26-000012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676170-26-000012","line_url":"/filing/0001676170-26-000012","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3993.0,"shares_display":"3,993","price_per_share":26.00073365890308,"price_display":"26.00","price_state":"stated","total_value":103820.9295,"total_display":"103,820.93","total_whole":"103,821","shares_owned_after":25930.0,"shares_owned_after_display":"25,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":2},{"id":5948870,"accession":"0001676170-26-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676170-26-000009","line_url":"/filing/0001676170-26-000009","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6643.0,"shares_display":"6,643","price_per_share":26.200221074815595,"price_display":"26.20","price_state":"stated","total_value":174048.0686,"total_display":"174,048.07","total_whole":"174,048","shares_owned_after":344897.0,"shares_owned_after_display":"344,897","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider","n_lines":2},{"id":6078126,"accession":"0001676170-26-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001676170-26-000007","line_url":"/filing/0001676170-26-000007#line-3","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25582.0,"shares_display":"25,582","price_per_share":26.015,"price_display":"26.02","price_state":"stated","total_value":665515.73,"total_display":"665,515.73","total_whole":"665,516","shares_owned_after":350987.0,"shares_owned_after_display":"350,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-26","filed_date":"2026-05-27","scope":"insider"},{"id":6078124,"accession":"0001676170-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676170-26-000007","line_url":"/filing/0001676170-26-000007","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6982.0,"shares_display":"6,982","price_per_share":26.000064508736752,"price_display":"26.00","price_state":"stated","total_value":181532.4504,"total_display":"181,532.45","total_whole":"181,532","shares_owned_after":376569.0,"shares_owned_after_display":"376,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-22","filed_date":"2026-05-27","scope":"insider","n_lines":2},{"id":5757961,"accession":"0001676170-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001676170-26-000004","line_url":"/filing/0001676170-26-000004","is_derivative":false,"issuer_cik":"0001676170","issuer_name":"Maze Therapeutics, Inc.","issuer_ticker":"MAZE","issuer_name_source":null,"issuer_url":"/issuer/0001676170","owner_cik":"0001676170","owner_name":"Coloma Jason V","owner_display_name":"Coloma Jason V","owner_url":"/insider/0001676170","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1938.0,"shares_display":"1,938","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":50388.0,"total_display":"50,388.00","total_whole":"50,388","shares_owned_after":381073.0,"shares_owned_after_display":"381,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001842295","name":"Maze Therapeutics, Inc.","url":"/issuer/0001842295","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2026-05-18","last_seen":"2026-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001676170","retrieved_at":"2026-08-22T19:14:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}